West Pharmaceutical Services, Inc. Stock
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.11 USD | +2.85% |
|
-0.59% | -29.75% |
| Capitalization | 16.64B 15.29B 14.72B 12.88B 23.95B 1,447B 26.34B 169B 63.96B 610B 62.37B 61.11B 2,467B | P/E ratio 2025 * |
37.9x | P/E ratio 2026 * | 32.6x |
|---|---|---|---|---|---|
| Enterprise value | 15.75B 14.48B 13.93B 12.19B 22.67B 1,369B 24.94B 160B 60.55B 578B 59.04B 57.85B 2,336B | EV / Sales 2025 * |
5.45x | EV / Sales 2026 * | 5x |
| Free-Float |
95.72% | Yield 2025 * |
0.36% | Yield 2026 * | 0.38% |
More valuation ratios
* Estimated data
More news
Last Transcript: West Pharmaceutical Services, Inc.
More recommendations
More press releases
More news
| 1 day | +2.85% | ||
| 1 week | -0.59% | ||
| Current month | -0.96% | ||
| 1 month | +7.16% | ||
| 3 months | -30.39% | ||
| 6 months | -22.46% | ||
| Current year | -29.75% |
1 week
220.53
230.11
1 month
201.25
230.11
Current year
197.01
230.11
1 year
197.01
230.11
3 years
197.01
230.11
5 years
124.53
230.11
10 years
52.73
230.11
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 2015-04-23 |
Bernard Birkett
DFI | Director of Finance/CFO | 56 | 2018-06-20 |
Quintin Lai
IRC | Investor Relations Contact | 58 | 2016-01-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Hofmann
BRD | Director/Board Member | 73 | 2007-10-15 |
Mark Buthman
BRD | Director/Board Member | 64 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 68 | 2011-03-06 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.85% | -0.59% | -40.64% | -42.00% | 16.64B | ||
| -2.45% | -7.61% | +9.72% | +6.05% | 220B | ||
| +0.80% | -1.51% | +11.37% | -13.26% | 119B | ||
| +1.43% | -1.55% | -4.53% | -13.35% | 64.89B | ||
| +0.80% | +1.37% | +8.33% | +71.48% | 50.04B | ||
| +0.32% | +0.26% | -10.31% | +27.72% | 40.32B | ||
| +3.23% | -9.19% | -45.81% | -35.34% | 27.62B | ||
| +0.34% | +2.37% | -4.73% | +49.42% | 27.42B | ||
| +1.88% | -2.63% | -1.49% | -0.18% | 22.27B | ||
| +2.23% | +1.83% | -12.14% | -9.85% | 21.89B | ||
| Average | +1.14% | -1.67% | -9.02% | +4.07% | 61.02B | |
| Weighted average by Cap. | -0.10% | -3.40% | +1.36% | +4.97% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.89B 2.66B 2.56B 2.24B 4.16B 251B 4.58B 29.33B 11.12B 106B 10.84B 10.62B 429B | 3.08B 2.83B 2.73B 2.39B 4.44B 268B 4.88B 31.27B 11.85B 113B 11.56B 11.32B 457B |
| Net income | 445M 409M 393M 344M 640M 38.67B 704M 4.51B 1.71B 16.31B 1.67B 1.63B 65.95B | 531M 488M 470M 411M 765M 46.18B 841M 5.39B 2.04B 19.48B 1.99B 1.95B 78.77B |
| Net Debt | -888M -816M -785M -687M -1.28B -77.19B -1.41B -9B -3.41B -32.56B -3.33B -3.26B -132B | -1.22B -1.12B -1.08B -946M -1.76B -106B -1.94B -12.4B -4.7B -44.82B -4.58B -4.49B -181B |
More financial data
* Estimated data
Employees
10,600
Calendar
Mar. 19
- KeyBanc Healthcare Forum
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-03-14 | 230.11 $ | +2.85% | 1,027,164 |
| 25-03-13 | 223.73 $ | -0.22% | 1,074,079 |
| 25-03-12 | 224.23 $ | -2.83% | 949,206 |
| 25-03-11 | 230.77 $ | +2.09% | 1,264,902 |
| 25-03-10 | 226.04 $ | -2.35% | 1,142,318 |
Delayed Quote Nyse, March 14, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
230.11USD
Average target price
286.12USD
Spread / Average Target
+24.34%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WST Stock